Spots Global Cancer Trial Database for ductal breast carcinoma
Every month we try and update this database with for ductal breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer | NCT00616967 | Breast Cancer | carboplatin paclitaxel albu... vorinostat placebo | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Broccoli Sprout Extract in Treating Patients With Breast Cancer | NCT01753908 | Ductal Breast C... Ductal Breast C... Estrogen Recept... Estrogen Recept... Invasive Breast... Lobular Breast ... Postmenopausal Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | Broccoli Sprout... Laboratory Biom... Pharmacological... Placebo | 21 Years - | Roswell Park Cancer Institute | |
Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ | NCT00002934 | Breast Cancer | long-term scree... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial | NCT00002900 | Breast Cancer Cardiac Toxicit... | management of t... | 18 Years - 120 Years | SWOG Cancer Research Network | |
Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer | NCT00870415 | Breast Cancer | quality-of-life... therapeutic con... | 18 Years - 120 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
Clinical Trial of Trametes Versicolor in Women With Breast Cancer | NCT00680667 | Breast Cancer | Coriolus versic... | 21 Years - 75 Years | Masonic Cancer Center, University of Minnesota | |
Biological Therapy in Treating Women With Stage IV Breast Cancer | NCT00027807 | Breast Cancer | Aldesleukin Sargramostim therapeutic aut... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00097344 | Breast Neoplasm... Neoplasms, Horm... | Atamestane Toremifene Letrozole Aromatase inhib... Estrogen recept... Hormone therapy Endocrine thera... Antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | NCT03414970 | Ductal Breast C... Invasive Breast... Lobular Breast ... Medullary Breas... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Tubular Breast ... | Radiation Thera... Questionnaire A... Quality-of-Life... Laboratory Biom... Hypofractionate... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | NCT00044291 | Breast Neoplasm... Neoplasms, Horm... | atamestane toremifene letrozole aromatase inhib... hormone therapy endocrine thera... antiestrogen th... | 18 Years - | Intarcia Therapeutics | |
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer | NCT00616967 | Breast Cancer | carboplatin paclitaxel albu... vorinostat placebo | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | NCT00004205 | Breast Cancer | letrozole tamoxifen citra... | 30 Years - 120 Years | ETOP IBCSG Partners Foundation | |
Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer | NCT00870415 | Breast Cancer | quality-of-life... therapeutic con... | 18 Years - 120 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma | NCT03909282 | Ductal Breast C... | Lumpectomy Partial breast ... | 18 Years - | Stanford University | |
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | NCT00267553 | Breast Neoplasm... Neoplasms, Horm... | Atamestane toremifene letrozole | 18 Years - | Intarcia Therapeutics | |
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | NCT00004205 | Breast Cancer | letrozole tamoxifen citra... | 30 Years - 120 Years | ETOP IBCSG Partners Foundation | |
Living Well After Breast Surgery | NCT03834532 | Breast Cancer F... Stage I Breast ... Stage II Breast... Stage III Breas... Ductal Carcinom... Ductal Breast C... Lobular Breast ... | Breast reconstr... Educational web... | 18 Years - | University of Texas at Austin | |
Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ | NCT00002934 | Breast Cancer | long-term scree... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |